ArticleThe lancet. HIV2023

Pharmacokinetics, safety, and tolerability of dispersible and immediate-release abacavir, dolutegravir, and lamivudine tablets in children with HIV (IMPAACT 2019): week 24 results of an open-label, multicentre, phase 1-2 dose-confirmation study.

Kristina M Brooks et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.